Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 07, 2018

SELL
$44.22 - $75.47 $10.2 Million - $17.3 Million
-229,608 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$72.38 - $92.5 $1.38 Million - $1.76 Million
-19,065 Reduced 7.67%
229,608 $18.3 Million
Q1 2018

May 14, 2018

SELL
$69.46 - $88.57 $4.18 Million - $5.33 Million
-60,146 Reduced 19.48%
248,673 $21.6 Million
Q4 2017

Feb 13, 2018

SELL
$65.94 - $93.31 $4.91 Million - $6.94 Million
-74,428 Reduced 19.42%
308,819 $21.3 Million
Q3 2017

Nov 07, 2017

SELL
$80.87 - $91.08 $13.4 Million - $15.1 Million
-165,688 Reduced 30.18%
383,247 $34.8 Million
Q2 2017

Aug 10, 2017

BUY
N/A
548,935
548,935 $40.9 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.